Pharmacokinetics of reboxetine in healthy, elderly volunteers.

作者: J. F. Bergmann , J P Laneury , P. Duchene , J C Fleishaker , G. Houin

DOI: 10.1007/BF03192313

关键词:

摘要: The pharmacokinetic characteristics of reboxetine, a unique selective noradrenaline reuptake inhibitor (selective NRI) for the treatment depression, were studied in 12 healthy, elderly volunteers (mean age 81 years ±9 years). All subjects received single 4-mg dose and plasma reboxetine concentrations measured by HPLC.

参考文章(9)
M Mucci, Reboxetine: a review of antidepressant tolerability. Journal of Psychopharmacology. ,vol. 11, ,(1997)
Tsujimoto G, Hoffman Bb, Hashimoto K, Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 2. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 27, pp. 102- 116 ,(1989)
C. Katona, Rationalizing antidepressants for elderly people. International Clinical Psychopharmacology. ,vol. 10, pp. 37- 40 ,(1995) , 10.1097/00004850-199503001-00007
D. M. F. Edwards, C. Pellizzoni, H. P. Breuel, A. Berardi, M. G. Castelli, E. Frigerio, I. Poggesi, M. Rocchetti, A. Dubini, M. Strolin Benedetti, Pharmacokinetics of reboxetine in healthy volunteers. Single oral doses, linearity and plasma protein binding Biopharmaceutics & Drug Disposition. ,vol. 16, pp. 443- 460 ,(1995) , 10.1002/BDD.2510160603
Philippe Dostert, Margherita S. Benedetti, Italo Poggesi, Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor European Neuropsychopharmacology. ,vol. 7, ,(1997) , 10.1016/S0924-977X(97)00417-3
Joseph C. Fleishaker, Massimiliano Mucci, Cinzia Pellizzoni, Italo Poggesi, Absolute bioavailability of reboxetine enantiomers and effect of gender on pharmacokinetics. Biopharmaceutics & Drug Disposition. ,vol. 20, pp. 53- 57 ,(1999) , 10.1002/(SICI)1099-081X(199901)20:1<53::AID-BDD157>3.0.CO;2-P
Michael J. Hauer, Michael A. Wynalda, Larry C. Wienkers, Cecilia Allievi, Cytochrome P-450-Mediated Metabolism of the Individual Enantiomers of the Antidepressant Agent Reboxetine in Human Liver Microsomes Drug Metabolism and Disposition. ,vol. 27, pp. 1334- 1340 ,(1999)
Montgomery Sa, Reboxetine: additional benefits to the depressed patient. Journal of Psychopharmacology. ,vol. 11, ,(1997)
S H Preskorn, Recent pharmacologic advances in antidepressant therapy for the elderly. The American Journal of Medicine. ,vol. 94, ,(1993)